BVS FY 2024 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$573M+11.9% YoY

Gross Profit

$388M67.7% margin

Operating Income

-$12M-2.1% margin

Net Income

-$34M-5.9% margin

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$38M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$728M

Total Liabilities

$542M

Stockholders' Equity

$148M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$573M	$512M	+11.9%
Gross Profit	$388M	$328M	+18.3%
Operating Income	-$12M	-$82M	+85.3%
Net Income	-$34M	-$156M	+78.5%